BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10625079)

  • 1. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.
    Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M
    Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
    Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
    J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
    Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
    Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
    Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M
    Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin.
    Chan NL; Bourdeau A; Vera S; Abdalla S; Gross M; Wong J; Cymerman U; Paterson AD; Mullen B; Letarte M
    Placenta; 2004; 25(2-3):208-17. PubMed ID: 14972453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes.
    Sanz-Rodriguez F; Fernandez-L A; Zarrabeitia R; Perez-Molino A; Ramírez JR; Coto E; Bernabeu C; Botella LM
    Clin Chem; 2004 Nov; 50(11):2003-11. PubMed ID: 15375013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
    Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
    J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function.
    Paquet ME; Pece-Barbara N; Vera S; Cymerman U; Karabegovic A; Shovlin C; Letarte M
    Hum Mol Genet; 2001 Jun; 10(13):1347-57. PubMed ID: 11440987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia.
    Cymerman U; Vera S; Karabegovic A; Abdalla S; Letarte M
    Hum Mutat; 2003 May; 21(5):482-92. PubMed ID: 12673790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.
    Bourdeau A; Faughnan ME; Letarte M
    Trends Cardiovasc Med; 2000 Oct; 10(7):279-85. PubMed ID: 11343967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia.
    Kjeldsen AD; Møller TR; Brusgaard K; Vase P; Andersen PE
    J Intern Med; 2005 Oct; 258(4):349-55. PubMed ID: 16164574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan.
    Dakeishi M; Shioya T; Wada Y; Shindo T; Otaka K; Manabe M; Nozaki J; Inoue S; Koizumi A
    Hum Mutat; 2002 Feb; 19(2):140-8. PubMed ID: 11793473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.
    Letteboer TG; Mager JJ; Snijder RJ; Koeleman BP; Lindhout D; Ploos van Amstel JK; Westermann CJ
    J Med Genet; 2006 Apr; 43(4):371-7. PubMed ID: 16155196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
    Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
    Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect.
    Gallione CJ; Scheessele EA; Reinhardt D; Duits AJ; Berg JN; Westermann CJ; Marchuk DA
    Hum Genet; 2000 Jul; 107(1):40-4. PubMed ID: 10982033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
    Azuma H
    J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.